Maris P.
- Country
- Estonia
- Department
- 233001; Hematology-Oncology Clinic
Research Overview
- Phase II Open‑Label Multicenter Study of Teclistamab + Pomalidomide in Relapsed/Refractory Multiple Myeloma after 1–3 Prior Lines including Lenalidomide and Anti‑CD38
- R-MINI-CHOP versus R-MINI-CHP in combination with polatuzumab-vedotin, as primary treatment for patients with diffuse large B-cell lymphoma, ≥80 years, or frail ≥75 years – an open label randomized Nordic Lymphoma Group phase III trial - NLG-LBC7 (POLAR BEAR)
- Phase 3 Study of Daratumumab, Lenalidomide, Dexamethasone, and Linvoseltamab in Newly Diagnosed Transplant-Ineligible Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 10 of 107 partner sites.
Specializations
Hematologic Oncology
This investigator specializes in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL), focusing on developing innovative therapeutic approaches for this aggressive form of blood cancer.
- B-cell lymphoma management
- Advanced lymphoma therapies
- Hematologic malignancies
The investigator's work centers on evaluating novel combination therapies for enhanced treatment outcomes in lymphoma patients.
Therapeutic Innovation
Expertise includes the development and assessment of targeted therapeutic combinations for hematological conditions, with particular attention to optimizing treatment protocols.
- Combined modality treatments
- Treatment optimization strategies
- Novel therapeutic approaches
The research focuses on comparing different therapeutic regimens to establish more effective treatment standards.
Clinical Research
Active involvement in comparative efficacy studies within the field of lymphoma treatment, evaluating various therapeutic combinations to improve patient outcomes.
- Treatment efficacy assessment
- Clinical outcomes research
- Therapeutic protocol development
The investigator evaluates modified treatment regimens to enhance therapeutic effectiveness in lymphoma care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.